tumor protein p63 regulated 1 like pseudogene 1Genealiases: []
Q-omics provides the consensus-scored TPRG1LP1 profile across patient tissues and cancer cell-line models. TPRG1LP1 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, TPRG1LP1 is differentially expressed in 10, with the highest sampling consensus in BRCA. Additionally, TPRG1LP1 RNA expression shows 15,379 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight THCA, BRCA, and THYM as cancer lineages where TPRG1LP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TPRG1LP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TPRG1LP1 survival associations across molecular data types. TPRG1LP1 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TPRG1LP1 RNA expression–survival associations across cancer types. High TPRG1LP1 expression shows unfavorable associations in LUSC and MESO, but favorable associations in THCA, KIRP, ACC and THYM. The THCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for TPRG1LP1 RNA expression.
This table summarizes TPRG1LP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for TPRG1LP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TPRG1LP1 shows lower tumor expression in BRCA and higher tumor expression in COAD, HNSC, KICH, LUAD and STAD. The BRCA box plot shows higher TPRG1LP1 RNA expression in normal versus tumor tissue (log2 FC = −0.175, t-test p < 0.001).
This table shows molecular features associated with TPRG1LP1 in patient tissues and cancer cell lines. In patient samples, TPRG1LP1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
